Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. $9.7 million awarded to kidney transplantation research

$9.7 million awarded to kidney transplantation research

Stories Jan 23, 2018 3 minutes

Funding supports VCH researchers whose new treatments could revolutionize patient care.

Genome Canada has awarded $9.7 million to a project co-led by researchers at Vancouver Coastal Health (VCH) that could change the face of transplant care. The funding will support a groundbreaking study—co-led by Dr. Paul Keown and Dr. Stirling Bryan from University of British Columbia, Dr. Ruth Sapir-Pichhadze from McGill University and Dr. Timothy Caulfield from University of Alberta—that aims to increase kidney transplant success rates by 50 per cent and save around $1-billion in health care costs over the next 15 years.

“With the funds from this award, we are working to identify new clinical interventions to increase survival rates and quality of life for transplant patients and their families,” says Keown, professor and director of Immunology and founding head of the BC Transplant Program, now one of the largest and most successful in North America. “The knowledge and expertise gained throughout this project has the potential to be transferred to other types of transplantation, which could be revolutionary.”

The BC-led project—Precision Medicine CanPREVENT AMR: Applying precision medicine technologies in Canada to prevent antibody-mediated rejection and premature kidney transplant loss—involves research teams throughout Canada (Alberta, Quebec, Ontario and Nova Scotia) and the world (United Kingdom, European Union and United States). 

Researchers involved in the project are using genetic technologies to better match kidney donors with patients. Through advanced procedures, they are investigating how to better monitor the immune response that causes a transplant to be rejected and to intervene before this occurs. Teams are also designing personalized medicine for patients using novel “systems pharmacology” approaches that will prevent rejection and avoid associated health risks. 

“Transplantation remains the optimal treatment for patients with kidney failure, but rejection continues to affect as many as 30 per cent of recipients,” says Bryan, professor and director of the Centre for Clinical Epidemiology and Evaluation (C2E2). “The goal of our project is to cut the rejection rate in half using genomic technologies. This has the potential to save the transplanted kidneys of approximately 500 Canadians each year and dramatically reduce the need for dialysis and re-transplantation.”

The Large-Scale Applied Research Project Competition—a partnership between Genome Canada, the Canadian Institutes of Health Research and project co-funding partners—awarded $162-million over four years to 15 genomics and precision health projects that improve health outcomes for patients and enhance the cost-effectiveness of delivering health care in Canada.
    
On top of improving treatments for kidney and potentially other transplant patients, the Precision Medicine CanPREVENT AMR study will examine the legal and ethical ramifications of introducing these strategies to health care practitioners. The project will also identify societal and economic barriers to adopting these innovations and develop effect strategies to address them.


Award background

Genome Canada, in collaboration with the Canadian Institutes of Health Research and project co-funding partners, has invested approximately $162-million over four years in 15 new genomics and precision health projects. These projects—spanning multiple disease areas—demonstrate how genomics-based research can contribute to a more evidence-based approach to health and thereby improve health outcomes for patients, as well as enhance the cost-effectiveness of Canada’s health care system.

 


 

Researchers

Paul Keown
Stirling Bryan

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Centre for Clinical Epidemiology and Evaluation

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy